Method to deliver compositions conferring resistance to alopecia to hair follicles
AssigneeAntiCancer, Inc.
InventorsValeryi Lishko, Lingna Li
Life of this patent
Estimating the term…
Abstract
The invention describes a method to deliver a composition selectively to hair follicles using a liposomal formulation. Proteins which are cell cycle inhibitors are products of the multi-drug resistance gene or the recombinant materials for their production are targeted to hair follicles by encapsulating them in liposomes.
Claims21
A method to introduce a composition which contains at least one active ingredient which is effective to inhibit the loss of hair caused by a chemotherapeutic agent selectively to the hair follicles of a subject without transmission to the cells external to the hair follicles so as to prevent hair loss induced by chemotherapy in said subject in need of such prevention which method comprises
- applying to the skin of said subject in an area where prevention of hair loss is desired and which contains hair follicles, a formulation comprising said composition wherein said at least one active ingredient, when contained in the cells of a hair follicle, prevents the chemotherapeutic agent-induced loss of hair extruded from said hair follicle,
- said formulation being a liposomal formulation wherein said liposomes target said composition selectively into the hair follicle cells by transfer into the follicle without entry into the circulation or the adjacent skin tissue and
- wherein said active ingredient is a protein which is a cell cycle inhibitor, or
- wherein said active ingredient is the protein product of the multidrug resistance (MDR) gene, or
- wherein said composition comprises an expression system for the production of an effective amount of a protein which is a cell cycle inhibitor, or
- wherein said composition comprises an expression system for the production of an effective amount of the product of the MDR gene.
A liposomal formulation for delivery of a composition to hair follicles by transfer into the follicle without entry into the circulation or skin tissue adjacent to the follicle wherein said composition comprises at least one active ingredient which, when contained in the cells of a hair follicle, prevents chemotherapeutic agent-induced loss of hair extruded from said hair follicle and
- wherein said active ingredient is a protein which is a cell cycle inhibitor, or
- wherein said active ingredient is the protein product of the multidrug resistance (MDR) gene, or
- wherein said composition comprises an expression system for the production of an effective amount of a protein which is a cell cycle inhibitor, or
- wherein said composition comprises an expression system for the production of an effective amount of the product of the MDR gene.
Dependencies are inferred from the claim text.